Avalon Pharma stocks test support

The stock of Al Sharq Al Awsat Pharmaceuticals "Avalon Pharma" has experienced price fluctuations recently, entering a consolidation phase between the support levels of 62.50 and 63.05 SAR. Following strong gains in August that led to profit-taking, the stock now needs to break through the key resistance level at 65.00 SAR to improve its chances of climbing higher. This move should be supported by a noticeable increase in trading volumes, which could open the door to price targets ranging between 66.60 and 69.05 SAR. Analysts warn that further corrections may occur if support at 63.05 SAR disappears, as breaking this level would pose a risk to the continuation of the upward trend.

articleDetails.fontSize.sizeحجم النص

تنويه: هذا ملخص تم إنشاؤه بواسطة الذكاء الاصطناعي

عرض المقال بالكامل